Experimental Ebola Treatment Trial Begins in Congo
Quick Look
- A trial for two experimental Ebola treatments, remdesivir and MBP134, has started in eastern Congo's Ituri province amid the largest-ever Ebola outbreak.
- The trial aims to improve survival rates for patients diagnosed with the Bundibugyo virus.
AI-generated summary
A trial for two experimental Ebola treatments, remdesivir and MBP134, has started in eastern Congo's Ituri province amid the largest-ever Ebola outbreak. The trial aims to improve survival rates for patients diagnosed with the Bundibugyo virus.

